Literature DB >> 19859720

Rectal cancer: quo vadis, neoadjuvant and adjuvant (chemo) radiotherapy?

Rainer Fietkau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19859720     DOI： 10.1007/s00384-009-0825-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  13 in total

1.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

2.  Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients.

Authors:  Rainer Fietkau; Gunther Klautke
Journal:  J Clin Oncol       Date:  2008-01-20       Impact factor: 44.544

3.  Non-operative management of rectal cancer after neoadjuvant chemoradiation.

Authors:  A Habr-Gama; R O Perez
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

4.  Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

Authors:  Carlo Capirci; Vincenzo Valentini; Luca Cionini; Antonino De Paoli; Claus Rodel; Robert Glynne-Jones; Claudio Coco; Mario Romano; Giovanna Mantello; Silvia Palazzi; Falchetti Osti Mattia; Maria Luisa Friso; Domenico Genovesi; Cristiana Vidali; Maria Antonietta Gambacorta; Alberto Buffoli; Marco Lupattelli; Maria Silvia Favretto; Giuseppe La Torre
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-11       Impact factor: 7.038

5.  Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.

Authors:  Morten Braendengen; Kjell M Tveit; Ake Berglund; Elke Birkemeyer; Gunilla Frykholm; Lars Påhlman; Johan N Wiig; Per Byström; Krzysztof Bujko; Bengt Glimelius
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

6.  The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.

Authors:  E Van Cutsem; M Dicato; K Haustermans; N Arber; J-F Bosset; D Cunningham; A De Gramont; E Diaz-Rubio; M Ducreux; R Goldberg; R Glynne-Jones; D Haller; Y-K Kang; D Kerr; R Labianca; B D Minsky; M Moore; B Nordlinger; P Rougier; W Scheithauer; H-J Schmoll; A Sobrero; J Tabernero; M Tempero; C Van de Velde; J Zalcberg
Journal:  Ann Oncol       Date:  2008-06       Impact factor: 32.976

7.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

8.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

Authors:  Laurence Collette; Jean-Francois Bosset; Marcel den Dulk; France Nguyen; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Marianne Piérart; Gilles Calais
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

9.  Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site.

Authors:  Lia Assumpcao; Michael A Choti; Ana Luiza Gleisner; Richard D Schulick; Michael Swartz; Joseph Herman; Susan L Gearhart; Timothy M Pawlik
Journal:  Arch Surg       Date:  2008-08

10.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321
View more
  1 in total

1.  Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it?

Authors:  M L Sautter-Bihl; W Hohenberger; R Fietkau; C Rödel; H Schmidberger; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-02       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.